Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.34 |
| ▸ | SHBG | P04278 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5665177 | 1.00 | ANPEP (0.34) | ANPEPENPEPSHBG | |
| SCHEMBL7608856 | 0.89 | — | — | |
| SCHEMBL8943205 | 0.81 | CPB2 (0.36) | ANPEPENPEP | |
| SCHEMBL2640244 | 0.81 | CPB2 (0.36) | ANPEPENPEP | |
| SCHEMBL7375737 | 0.80 | ALOX5 (0.34) | — | |
| SCHEMBL7375837 | 0.80 | — | — | |
| SCHEMBL7418539 | 0.78 | METAP1 (0.37) | — | |
| SCHEMBL1449256 | 0.78 | METAP1 (0.37) | — | |
| SCHEMBL3504941 | 0.78 | METAP1 (0.37) | — | |
| SCHEMBL10583764 | 0.75 | CPN1 (0.42) | ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5449612-A | Process for identifying candida by means of chromogenic substances | SERBIO (FR) | 1995-09-12 | — | — | US | claimed |
| EP-0280610-B1 | DIPEPTIDES, PREPARATION PROCESS AND USE IN DOSING PROTEASES | SERBIO (FR) | 1992-10-21 | — | — | EP | claimed |
| US-6121239-A | SPECIFIED TRI- AND TETRA-PEPTIDES | SERBIO (FR) | 2000-09-19 | — | — | US | disclosed |
| EP-0456567-B1 | Procedure to determine a plasminogen activator and its inhibitor | STAGO DIAGNOSTICA (FR) | 1998-01-07 | — | — | EP | disclosed |
| EP-0476107-B1 | PROCESS FOR IDENTIFYING CANDIDA ALBICANS BY MEANS OF CHROMOGENIC SUBSTANCES | STAGO DIAGNOSTICA (FR) | 1996-06-19 | — | — | EP | disclosed |
| US-5472851-A | Converting plasminogen to plasmin and the assaying plasmin resulting from said conversion; inhibiting plsma proteins alpha2-antiplsmin and alpha2-macroglobulin by contact with metalloproteinase | SERBIO (FR) | 1995-12-05 | — | — | US | disclosed |
| US-5449612-A | Process for identifying candida by means of chromogenic substances | SERBIO (FR) | 1995-09-12 | — | — | US | disclosed |
| EP-0472670-B1 | SYMMETRICAL BIPEPTIDES INCLUDING A POLYALKYLENE-GYLCOL GROUP, METHOD OF PREPARATION AND USE IN PROTEASE DETERMINATION | SERBIO (FR) | 1995-03-29 | — | — | EP | disclosed |
| EP-0472671-B1 | PEPTIDE SUBSTRATES FOR Xa FACTOR IDENTIFICATION | SERBIO (FR) | 1995-03-15 | — | — | EP | disclosed |
| US-5225532-A | SYMMETRICAL BIPEPTIDES CONTAINING A POLYALKYLENE GLYCOL RESIDUE, METHOD OF PREPARATION AND USE IN THE ASSAY OF PROTEASES | SERBIO (FR) | 1993-07-06 | — | — | US | disclosed |
| EP-0280610-B1 | DIPEPTIDES, PREPARATION PROCESS AND USE IN DOSING PROTEASES | SERBIO (FR) | 1992-10-21 | — | — | EP | disclosed |
| EP-0472671-A1 | PEPTIDE SUBSTRATES FOR Xa FACTOR IDENTIFICATION. | SERBIO (FR) | 1992-03-04 | — | — | EP | disclosed |
| EP-0456567-A1 | Procedure to determine a plasminogen activator and its inhibitor | DIAGNOSTICA STAGO (société anonyme) (FR) | 1991-11-13 | — | — | EP | disclosed |
| WO-1991014787-A1 | PROCESS FOR IDENTIFYING CANDIDA BY MEANS OF CHROMOGENIC SUBSTANCES | SERBIO (FR) | 1991-10-03 | — | — | WO | disclosed |
| WO-1991012263-A1 | SYMMETRICAL BIPEPTIDES INCLUDING A POLYALKYLENE-GYLCOL GROUP, METHOD OF PREPARATION AND USE IN PROTEASE DETERMINATION | SERBIO (FR) | 1991-08-22 | — | — | WO | disclosed |
| WO-1991012338-A1 | PEPTIDE SUBSTRATES FOR Xa FACTOR IDENTIFICATION | SERBIO (FR) | 1991-08-22 | — | — | WO | disclosed |
| EP-0280610-A1 | Dipeptides, preparation process and use in dosing proteases | SERBIO (FR) | 1988-08-31 | — | — | EP | disclosed |
| US-4598043-A | Method for quantitatively assaying blood coagulation factor XII in human plasma | PENTAPHARM AG (CH) | 1986-07-01 | — | — | US | disclosed |